Background and Purpose Evidence linking changes in calcium/calmodulin-dependent protein kinase II activity with ischemic cell death has been reported in animal models of global ischemia. The purpose of this study was to delineate the course of these changes after focal ischemia and to clarify the relation of changes in activity of calcium/calmodulin-dependent protein kinase II to the process of ischemic cell death.
D
isruption of calcium homeostasis has long been known to play a key role in cell death resulting from a variety of toxic injuries. 1 More recently, the phenomenon of calcium overload has been theorized to be important in the process of neuronal death in the excitotoxin hypothesis of ischemic injury. 25 According to this theory, the stimulation of excitatory amino acid receptors (both A/-methyl-D-aspartate [NMDA] and non-NMDA receptors) initially causes a movement of ions across cell membranes, resulting in neuronal swelling. 67 The second phase in this process is a delayed cell injury, which may be mediated in part by an influx of calcium into the cell. The elevation of intracellular calcium occurs via agonist-associated calcium channels, voltage-operated channels, and release of intracellular calcium stores. 8 After calcium entry, a complex cascade of events results in cell injury. The details of this process, not yet clearly defined, probably involve the following: alterations of cell energy metabolism induced by calcium overload, 910 activation of catabolic enzymes with degradation of structural pro-
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teins, activation of Upases and phospholipases, 11 -12 and the generation of superoxide radicals. 1314 The possible role of changes in activity of calcium-activated protein kinases, such as calcium/calmodulin-dependent protein kinase II (CaM-KII) and protein kinase C (PKC), during ischemia has recently received the attention of a number of investigators. 15 ' 21 CaM-KII is a calcium/calmodulin-dependent protein kinase found in high concentration in the central nervous system, particularly in dendritic arborizations where it constitutes 15% to 50% of the protein in postsynaptic densities. 22 There is evidence implicating CaM-KII in a variety of cell functions including regulation of gluconeogenesis and glycogenolysis, regulation of lipid and amino acid metabolism, neurotransmitter synthesis and release, cytoskeletal functions, modulation of ion channels, and the induction of long-term potentiation. 22 - 29 The notion that it may be involved in the process of excitotoxic injury derives from its dependence on calcium for activation, as well as other indirect evidence closely linking the changes in calmodulin and CaM-KII with the process of cellular injury. 1s-1s.2o.21jo The exact mechanism by which changes in CaM-KII activity occur and contribute to cell injury is not known, but because it is present in such large quantities, its inactivation likely results in loss of some critical function necessary for postischemic neuronal survival.
We recently described the changes occurring in CaM-KII after global ischemia with varying durations of ischemia and reperfusion. 17 However, it has been suggested that focal ischemia may harbor a condition particularly prone to the delayed form of excitotoxic injury. 3 - 31 In a review by Siesjo and Bengtsson, 3 the penumbral region, unique to focal ischemia, was described as a partially ischemic zone where energy charge may be low enough to trigger excitotoxicity but high enough to maintain calcium-dependent glutamate release. In addition, pH is high enough to maintain NMDA receptor function. For this reason we have chosen to extend our evaluation of CaM-KII changes to the focal model of ischemia, concentrating our efforts on distinguishing the changes occurring in the infarct core from those occurring in the border zone of the infarction.
Materials and Methods Surgery
Adult spontaneously hypertensive rats (weight, 224 to 288 g) were subjected to focal ischemia using an adaption of a tandem middle cerebral artery (MCA) and common carotid artery (CCA) occlusion model allowing for reperfusion.
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The rats were fasted overnight with free access to water and then anesthetized with intraperitoneal chloral hydrate before surgery. The femoral artery was cannulated with a polyethylene catheter for blood pressure monitoring. A microprobe thermometer (Yellow Springs Instrument Co, Yellow Springs, Ohio) was used to monitor skull temperature. Head temperature and rectal temperature were maintained at 36.6±0.5°C and 36.6±0.6°C, respectively. The left CCA was isolated through a midline incision and tagged with 3.0 silk suture. An incision was made through the temporalis muscle perpendicular to a line drawn between the external auditory ear canal and the lateral canthus of the right eye, and then the muscle was retracted with 4.0 silk suture. Under direct visualization with a surgical microscope (Zeiss, Germany) the left MCA was exposed through a 1 x 3 -mm rectangular burr hole situated 2 to 3 mm rostral to the fusion of the zygomatic arch with the squamosal bone. The beveled edge of a 23-gauge hypodermic needle was used to pierce and open the dura along the entire length of the burr hole. The needle from a 10-0, BV13O-5 Ethicon neurosurgical suture was placed under the MCA in a position rostral to the rhinal fissure, proximal to the major bifurcation of the MCA, and distal to the lenticulostriate arteries. Then the needle was rotated clockwise so that one end pointed toward the vertex forming a right angle to the bunhole, thus lifting the MCA from the brain surface and occluding MCA blood flow. Immediately after MCA occlusion, the left CCA was occluded using two atraumatic Heifetz aneurysm clips. Reperfusion was achieved by turning the needle under the MCA counterclockwise and removing it and then removing the aneurysm clips from the ipsilateral CCA. Reinstitution of blood flow was visually confirmed with the operating microscope. This technique produces a cortical infarction, almost completely sparing the deep white matter and basal ganglia.
Rats were subjected to one of three time intervals of ischemia (5 minutes, 30 minutes, and 1 hour) and were killed either immediately after ischemia or after 24 hours of reperfusion (n=4 at each of the six time points). There were two sham-operated groups killed either immediately after ischemia or 24 hours after the operation (n=4 for each group). Shamoperated animals underwent anesthesia, isolation of the CCA, drilling of the burr hole, and opening of the dura but were not subjected to any manipulation of the MCA.
The rats were killed by decapitation under chloral hydrate anesthesia. The brain was quickly removed, and a 3-mm-thick coronal slice was taken 7 mm from the frontal pole and immediately placed in ice-cold phosphate-buffered saline (PBS). The posterior face of the slice was confirmed to be in the region of the dorsal hippocampus. The time elapsed from decapitation to immersion of the cortical slice in cold PBS was 60 seconds. Five 2x2x3-mm consecutive sections of cortex were dissected from the left (ischemic) portion of this slice beginning at the center of the region of ischemia and moving to the vertex (Fig la) . This included regions from the core of the infarct (LI and L2), border-zone region (L3 and L4), and unaffected vertex (L5) as defined histologically in an animal subjected to 1 hour of ischemia with 23 hours of reperfusion. A similar section was taken from the right, nonischemic cortex in a region comparable to the infarct core (region R). Each section was homogenized in 500 fiL of cold buffer A (10 mmol/L tris(hydroxymethyl)aminomethane (pH 7.4), 1 mmol/L ethylene glycol-bis(£-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA), 1 mmol/L ethylenediaminetetraace-tic acid (EDTA), 0.5 mmol/L dithiothreitol, 0.1 mmol/L phenylmethylsulfonyl fluoride, 10 mg/L leupeptin, and 50 mg/L soybean trypsin inhibitor) with a Teflon/glass homogenizer using 30 strokes. Aliquots of homogenates were stored at -80°C. Protein concentration of homogenates was determined with a modification of the Lowry method using bovine serum albumin as a standard.
CaM-KII Assay
A synthetic peptide substrate (MHRQETVD; NTPj) was used to determine CaM-KII activity in the homogenates from each of the regions dissected. 17 ]ATP (3000 Ci/mmol). Every sample was also analyzed in reactions excluding calcium and calmodulin and containing 2 mmol/L EGTA (final concentration) as a measure of calcium/calmodulin-independent activity. Reactions were incubated at 30°C for 1 minute, and then 20 /xL of the mixture was spotted on P-81 phosphocellulose filters. Filters were then washed in 75 mmol/L phosphoric acid, and the remaining radioactivity was quantitated in a scintillation counter. This assay was previously described with a 20-/AITIO1/L NTPj concentration, and the reaction has been shown to be linear for up to 1.5 minutes with as much as 12 /ig of sample protein. 17 Greater than 80% of NTPj phosphorylation could be blocked by the addition of a specific peptide inhibitor of CaM-KII (CaM-KIIi; MHRQEAVDCLKKFNARRK-LKGA), 27 indicating that most of the activity measured represented phosphorylation by CaM-KII.
CaM-KII 50 -kD Subunit
The amount of enzyme in homogenate samples was evaluated in the animals with 5 minutes and with 1 hour of ischemia with no reperfusion to determine whether initial changes in enzyme activity before cell loss were due to degradation of the enzyme. Measurements were also carried out after 24 hours of reperfusion. This was semiquantitatively determined using a Western blot technique described previously. Thirty-five micrograms of protein from each sample was separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then was electrophoretically transferred onto nitrocellulose. The nitrocellulose paper was incubated first with a monoclonal antibody (2D5; 1:2000 dilution) specific to the 50-kD subunit of CaM-KII and subsequently with anti-mouse alkaline phosphatase-conjugated antibody. A colorimetric detection of the alkaline phosphatase activity was used to visualize the 50-kD subunit of CaM-KII. Densitometric analysis of the 50-kD band was performed using a computer-driven linear densitometer (Hoeffer, San Francisco, Calif), which represents the amount of this protein in arbitrary units of area under a curve. We expressed the results as a percent of activity detected in normal hemisphere (from region R) in the same animal.
Protein Kinase A Assay
Using the same homogenates used for CaM-KII assay, reactions of 50-^L volume and consisting of 10 mmol/L HEPES (pH 7.4), 0.4 mmol/L dithiothreitol, 10 Mmol/L cyclic AMP, 2 mmol/L EGTA, 30 ^mol/L kemptamide (LRRASLG; Peninsula Lab, Inc), 5 mmol/L MgCl 2 , 15 ^mol/L ATP, and 3 fid of -y-^PJATP (3000 Ci/mmol) were performed at 30°C. They were terminated after 1 minute by pipetting 20 /AL onto P-81 phosphocellulose filters. The filters were rinsed, and the remaining activity was counted as described above. Approximately 90% of the 32 P incorporated into kemptamide by protein kinase A (PKA) was inhibited by the peptide inhibitor of PKA, suggesting that other kinases contributed approximately 10% of the total phosphorylation in these reactions.
Data Analysis
Initially a multivariate ANOVA test was applied to all CaM-KII activity data, but the divergent changes with reperfusion (increase after 5 minutes of occlusion and further decrease after 30 to 60 minutes of occlusion) confounded interpretation of early changes in CaM-KII activity and the significance of the effect of reperfusion. For this reason it seemed inappropriate to only analyze the two groups (reperfusion and no reperfusion) together. Therefore, the PKA activity and CaM-KII activity data from the animals before reperfusion and CaM-KII activity data after reperfusion were subsequently each analyzed separately using a two-factor ANOVA (repeated-measures of region by time). Post hoc analysis was performed using Duncan's multiple range test to compare individual regions at separate time points of ischemia.
Histology
Ten rats exposed to 1 hour of occlusion with 23 hours of reperfusion and five rats exposed to 5 minutes of occlusion with 23.9 hours of reperfusion were analyzed for infarct volume in a manner previously described. 3 * In preparation, the animals were first perfused with phosphate-buffered 10% formalin. After perfusion with formalin, whole brains were dehydrated, cleared, and embedded in paraffin. Serial sections were cut at 5 fim in the coronal plane, and every 100th section (0.5-mm interval) was stained with a combination of hematoxylin and eosin and Luxol fast blue. This stain provides sharp demarcation of infarcted areas at low magnification and allows automated recognition by a color video-imaging system. Images of the sections were digitized with a DCTV (Digital Creations) frame grabber and analyzed with an Amiga 2000 computer (Commodore Business Machines). The infarcted area on each section was measured by counting recognized pixels, and the volume was calculated by representing each slice area mathematically as a circle and connecting their perimeters to form a solid model. The image analysis for volume of infarct was performed by a blinded investigator.
Results

Physiological Parameters
There were no differences between sham-operated and ischemic groups with respect to physiological parameters including weight, blood pressure after chloral hydrate anesthesia, head temperature, and rectal temperature. Mean arterial blood pressure measured before anesthesia was significantly lower in animals subjected to 30 minutes (133 ±4 mm Hg) and to 1 hour of ischemia (122±5 mm Hg) compared with sham-operated animals (155±14 mm Hg) (P<.05 for both groups). The differences in blood pressure were lost after the administration of anesthesia, making it unlikely that there was a significant influence on enzyme measurements or specific conclusions drawn in this study. In all other groups there was no difference between sham and ischemic animals with respect to preanesthesia blood pressure.
Histology
Rats subjected to 1 hour of ischemia with 23 hours of reperfusion had a mean infarct volume of 47.4±6.2 mm 3 . All these animals had a clearly defined infarct core where virtually all cortical cells were lost. This was the region measured on consecutive coronal slices for the calculation of infarct volume. At the level of the dorsal hippocampus (the region used for enzyme sampling), this region of completely infarcted tissue roughly corresponded to the location of sampling regions LI and L2 for enzyme assays. However, in many of the animals a border zone could be detected that stained lighter than normal cortex, microscopically showing some normal neurons, but with some cell loss as well (Fig lb) . Again at the level of the dorsal hippocampus, this region of incompletely infarcted tissue corresponded to sampling regions L3 and L4 for the enzyme assays. Animals with only 5 minutes of ischemia followed by 23.9 hours of reperfusion had no measurable infarct by these methods and little histologically detectable cell loss.
CaM-KII Assay
The repeated-measures ANOVA tests for effects of region by duration of ischemia and presence or absence of reperfusion demonstrated a significant effect for duration of ischemia (f=21.32, F=.0001) (Fig 2) . The Bar graph shows that calcium/caJmodulin-dependent protein kinase II (CAM-KII) activity In the cortex of animals subjected to varying periods of ischemia followed by immediate death Is significantly depressed In Infarct core (L1 and L2) and border-zone regions (L3 and L4) compared with the activity in shamoperated animals (mean±SD; n=4 for each group). Although the decrease In activity is dramatic even after only 5 minutes of ischemia, there appears to be a relation between the length of the ischemic interval and severity of the change. There Is also a relation between severity of the change and proximity of the region to the Ischemic core.
effect of reperfusion and the interaction of reperfusion and duration did not reach significance (f=2.42, P=.13> and f=1.35, P=.2%, respectively). One possible explanation for the absence of significance with the effect of reperfusion may have been that the changes in CaM-KII activity with reperfusion in different ischemic duration groups were divergent, so that small changes were cancelled out. CaM-KII activity in those animals subjected to 5 minutes of ischemia followed by 24 hours of reperfusion was higher than the activity in those animals subjected to the same period of ischemia without reperfusion (Fig 3) . In contrast, CaM-KII activity decreased further in the infarct zone in those animals subjected to 30 minutes and 60 minutes of ischemia followed by reperfusion when compared with animals subjected to these two durations of ischemia without reperfusion (Fig 3) . This divergent change would also dilute the immediate effect of ischemia in the 5-minute ) activity In the cortex of animals subjected to varying periods of Ischemia followed by 24 hours of reperfusion compared with sham-operated animals with 24-hour delay before death (mean±SD; n=4 for each group). There appears to be some recovery of activity in animals subjected to 5 minutes of ischemia after reperfusion (the absolute level of activity is higher than in the animals with 5 minutes of ischemia without reperfusion, and region L3 is no longer significantly decreased with respect to shamoperated animals). However, animals receiving 30 or 60 minutes of ischemia with 24 hours of reperfusion show a further decrease in CaM-KII activity during the reperfusion phase compared with groups receiving the same period of Ischemia but no reperfusion (the absolute level of activity is lower than In the animals with similar time of ischemia but no reperfusion, and the differences between the longer periods of ischemia with reperfusion and the 5-mlnute group reach significance). ischemia group when assessing animals with and without reperfusion as a single group. Therefore, we felt justified in a separate analysis of the two groups (ischemia without reperfusion and ischemia with reperfusion) using a two-factor ANOVA. A discussion of this analysis follows.
CaM-KII Assay: No Reperfusion
The repeated-measures ANOVA for effects of region by duration of ischemia for CaM-KII activity in the groups of animals without reperfusion demonstrated a significant effect for duration of ischemia, as expected (f=7.59, / > =.OO42). There was a significant effect when considering region (f=94.41, P=.0001) and an interaction between the variables of duration of ischemia and region affected (f= 14.78, />=.0001). The analyses of individual regions assessing the variable of ischemic duration showed a significant effect for regions in the ischemic core (LI and L2) as well as the outer regions (L3 and L4) ( Table 1) . Using Duncan's multiple range test, a significant decrease in activity compared with sham-operated animals was seen for all three durations of ischemia in three of these regions (LI, L2, L3) and in L4 in the animals subjected to 60 minutes of ischemia (Fig 2) . When comparing enzyme activity between the different durations of ischemia in these four regions, there appeared to be a graded response to ischemia based on both time of ischemia as well as proximity of the sample to the core of the infarct, with the most severe decline in activity noted closest to the ischemic core in animals subjected to longer periods of ischemia. For example, the activity detected in region LI (center of ischemic core) was decreased to a comparable degree after all three durations of ischemia compared with sham-operated rats. The activity in L2 and L3 after 5 or 30 minutes of ischemia, although significantly decreased when compared with the sham-operated group, was not as depressed as that seen after 60 minutes of ischemia (P<.05). Region L4, the ischemic region farthest from the core, only showed a significant depression in activity in the animals subjected to 60 minutes of ischemia (/ > <.O5). There was no significant decrease in activity in samples from the opposite hemisphere (region R, f=0.60 and P=.63) or from the nonischemic ipsilateral vertex (region L5, f=0.46 and P=.71). The regional differences correspond closely with previously published blood flow data in a similar model of focal ischemia in spontaneously hypertensive rats. 32 In a location similar to where our samples are chosen for CaM-KII activity analysis, the study by Brint et al 32 demonstrated cerebral blood flow of 22±4 mL/100 g per minute for infarct core (LI and L2), 34 ±3 mL/100 g per minute for border zone (L3 and L4), and 87±12 mL/100 g per minute at the vertex (L5).
CaM-KII Assay: Reperfusion
The repeated-measures ANOVA for effects of region by duration of ischemia for CaM-KII activity in the groups of animals with reperfusion demonstrated a significant effect for duration of ischemia (f= 16.03, P=.0OO2). There was a significant effect when considering region (f=43.34, / > =.0001) and an interaction between the variables of duration of ischemia and region affected (f= 11.77, P=.0O01). The analyses of individual regions assessing the variable of ischemic duration showed a significant effect for regions in the ischemic core (LI and L2) as well as the border of the ischemic area (L3 and L4) ( Table 2 ). Using Duncan's multiple range test, a significant decrease in activity compared with sham-operated animals was seen for all three durations of ischemia in the ischemic core (LI and L2, P<.05) and for both the 30-and 60-minute groups in the border zone (L3 and L4, P<.05) (Fig 3) . The changes with reperfusion among the different time points of ischemia were divergent, with a trend toward an increase in activity back to baseline in the 5-minute group and a trend toward further decrease in activity in the 30-and 60-minute groups with reperfusion. This resulted in a significant difference in activity in regions LI, L2, and L3 between the 5-minute group and the 30-minute group and in regions LI, L2, L3, and L4 between the 5-minute group and the 60-minute group. That is, there appeared to be a threshold for recovery of enzyme activity with reperfusion somewhere between 5 and 30 minutes of ischemia. Once again, no significant decreases in activity were noted in the opposite hemisphere (region R, f=0.93 and P=A5) or in the nonischemic ipsilateral vertex (region L5, f=0.73 and / > =.55).
Protein Kinase A Assay Protein kinase A activity was found to be significantly decreased in the ischemic zone (LI, P=.003; L2, P=.O2; L3, P=.O2; and L4, /»=.0O4). The univariate tests demonstrated a significant effect for region, but the effect of time was similar for all regions. This may be an indication that the changes in CaM-KII activity are relatively more specific for the ischemic insult compared with the changes seen in PKA activity (changes in CaM-KII are proportional to the severity and duration of the ischemia).
CaM-KII 50-kD Protein
No regional differences in CaM-KII 50-kD protein were discovered in animals subjected to 5 minutes or 1 hour of ischemia. The quantity of 50-kD protein detected in representative animals was expressed as a percentage of the nonoperated hemisphere. This was found to be 106% (LI) in infarct core and 103% (L3) and 105% (L4) in border-zone regions in an animal subjected to 5 minutes of ischemia without reperfusion. Similar measurements in an animal subjected to 1 hour of ischemia were 104% (LI) in infarct core and 101% (L3) and 92% (L4) in border-zone regions.
In animals with 5 minutes or 1 hour of ischemia followed by 24 hours of reperfusion, there was only a small decrease in 50-kD protein in ischemic regions compared with the nonischemic hemisphere (5 minutes of ischemia followed by 24 hours of reperfusion: LI, 81%, L3, 103%, and L4, 103%; 1 hour of ischemia followed by 24 hours of reperfusion: LI, 86%, L3, 76%, and L4, 87%).
Discussion
Our data demonstrate the extreme sensitivity of CaM-KII to ischemia, closely linking a decrease in its activity to the onset of ischemic injury. The change is immediate and dramatic, detected after only 5 minutes of a focal ischemic insult that does not produce histologically recognizable injury. The magnitude of the decrease in activity immediately after ischemia also correlated with increasing duration of ischemic insult. This has also been demonstrated by others in both global and focal ischemia models. In a rabbit spinal cord model of ischemic injury, Ziven et al 15 described significant decreases in PKC activity after 10 minutes of ischemia and in CaM-KII after 60 minutes of ischemia.
Dramatic decreases in CaM-KII activity have been seen in two separate models of global ischemia after only 5 minutes of occlusion in the gerbil and in the Wistar rat.' 7 ' 18 The level of CaM-KII activity continued to decrease during the reperfusion phase in those animals subjected to a period of ischemia sufficient in length to produce eventual infarction (30 minutes or longer). The changes in activity, which correlated with the pattern of infarction seen histologically after 24 hours of reperfusion, occurred despite relative absence of significant change in the quantity of enzyme present after reperfusion, indicating that reduction in CaM-KII activity was not merely due to destruction of the enzyme in concert with cell destruction, although this possibility cannot be completely excluded. We have observed similar reperfusion-associated decline in CaM-KII activity in recent experiments after 2 hours of ischemia and after 2 hours of ischemia with 2 hours of reperfusion, supporting the notion that there is an actual reduction in CaM-KII activity during reperfusion that occurs before cell destruction. Ideally, the current study should have been designed to sample a point after reperfusion before maturation of the cortical infarct. The continued decline of activity may implicate CaM-KII downregulation as an important factor in a delayed injury process after reperfusion, but these data cannot confirm this because of the degree of maturation of infarction present at 24 hours. Further studies of enzyme activity at different time points after reperfusion may clarify the course of these changes in relation to reperfusion, the process of cell death, and the maturation of the infarction. Further definition of this relation may have implications for the optimal use of neuroprotective agents aimed at maintaining calcium homeostasis after human stroke; they may be used to best advantage if started before reperfusion.
The changes in CaM-KII activity appear to be distinctive, in that other enzymes are either unaltered by the insult or require a longer ischemic insult to show any change in activity. We found only limited changes in PKA activity with shorter periods and only a modest decrease after 1 hour of focal ischemia with no reperfusion. Our findings were similar in the global model, showing a less dramatic decrease in PKC but no significant decrease in PKA activity after 5, 10, or 20 minutes of ischemia. 17 Similarly, Ziven et al 15 showed significant decreases in both PKC and CaM-KII in the rabbit spinal cord, but changes in PKA did not reach significance.
The close relation of CaM-KII alterations and ischemic injury is also implied by the pattern of decline of CaM-KII activity in the regions of cortex that were sampled. The most profound decrease was seen in the core of the infarct, with progressively less change in samples moving out from the core to border-zone regions. This graded change in CaM-KII activity corresponds closely to the degree of depression in blood flow that was demonstrated in a similar model of focal ischemia. 32 In like manner, the pattern of histological damage seen on coronal sections, at the same level as that used for sampling CaM-KII activity, is also similar to the pattern of depression in enzyme activity.
The mechanism of CaM-KII downregulation is unclear, but after global ischemia we have demonstrated translocation of enzyme in neurons from the cytosolic to the paniculate fraction where CaM-KII is no longer active.' 7 Our own work as well as the work of Others suggests that CaM-KII during the initial minutes of ischemia undergoes posttranslational modification characterized by aberrant phosphorylation 37 and change in affinity to ATP and anti-CaM-KII specific antibody.
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We have shown by immunostaining that binding of calcium to calmodulin and brain protein occurs in the same brain regions as downregulation of CaM-KII in a similar graded relation to ischemic duration and distance from the ischemic core, 40 and that calcium-calmodulin binding and downregulation of CaM-KII activity can be prevented by dextrorphan, an antagonist of the glutamate ligand gated calcium channel. 41 It appears, therefore, that CaM-KII downregulation results from calcium influx into neurons. Its downregulation probably results in loss of some critical (but as yet still unidentified) CaM-KII-related function necessary for cell survival.
In summary, the extreme sensitivity of this enzyme to focal ischemia with rapid decline in activity after short periods of ischemia and the further decline in activity during reperfusion (following a threshold duration of ischemia) may implicate changes in CaM-KII-mediated events in the process of delayed cell death or in socalled reperfusion injury. Although this does not constitute direct evidence, these data add to the increasing indirect evidence closely linking changes in CaM-KII to the process of ischemic cell death. Whether these changes are an integral part of the process, and the exact mechanism by which this downregulation might result in cell injury, are yet to be determined.
Editorial Comment
Calcium has been implicated as a major second messenger system involved in delayed neuronal cell death in numerous brain injury models. A major thrust of stroke research is to understand the mechanisms that mediate some of the effects of brain injury on calciumregulated systems at the biochemical and molecular levels. Calcium/calmodulin-dependent protein kinase II (CaM-KII) is a major calcium-regulated enzyme system and has been implicated in mediating many of the effects of calcium on neuronal function. Thus, regulation of this enzyme has numerous effects on cell structure and function. Recent research has indicated that CaM-KII activity is especially sensitive to ischemic injury. It is important to establish whether the effect of ischemia or brain injury on CaM-KII activity is important in mediating the effect of ischemia on cell function producing delayed neuronal cell death.
The accompanying article by Hanson et al is an important report from the stroke and neuroscience research group at the University of Texas that provides significant insight into the role of this major enzyme system in brain injury. This article demonstrates that CaM-KII activity is downregulated in a focal ischemia model in rat that can be carefully studied anatomically to correlate the degree and distribution of neuronal injury with the level of CaM-KII activity. The importance of this article is that it provides stronger evidence that there is a cause and effect link between the effect of ischemia on CaM-KII and the development of delayed cell death. This report was able to demonstrate both temporal and anatomic correlations between brain injury and changes in CaM-KII activity. These results further substantiate the importance of this major calcium second messenger system in the pathophysiology of brain injury.
The current research in this field suggests that there is a posttranscriptional modification of CaM-KII almost immediately after ischemic injury in brain tissue. This modification in the activity of this major calcium-calmodulin second messenger system may produce profound effects on cell function that then set in motion the process of delayed neuronal cell death. Although further research is needed to clearly prove that this enzyme is involved in the cause of cell death rather than the result of cell death, this article by the University of Texas research team provides a major step toward making this association. Further research on the effects of ischemia and brain injury on CaM-KII may provide an important insight into a molecular understanding of the mechanisms involved in mediating brain injury. The effect of decreased CaM-KII activity on cell function is another important area that warrants further investigation. Understanding these basic mechanisms may provide new insights into developing specific therapeutic interventions to prevent or minimize the resultant brain injury during the time that precedes delayed neuronal cell death.
